WHWK CLUSTER SEC Filing Analysis

Latest settled — T+20d

WHWK ▲ +16.90% at T+20d

SHORT call ✗ call lost -16.90% · α vs SPY -9.33% · entry $3.55 → $4.15

Next anchor: T+60d in 23d

Currently $4.22 · -18.87% from $3.55 entry (call sign-flipped)

Entry anchored
Apr 8, 03:59 PM ET
via Databento tick

T+1d

-4.51%

call +4.51% · α +4.45%

$3.39

settled 2mo ago

T+5d

+19.15%

call -19.15% · α -15.97%

$4.23

settled 8w ago

T+20d

+16.90%

call -16.90% · α -9.33%

$4.15

settled 5w ago

T+60d

—

call — · α —

—

in 23d

Price Chart

Loading chart...

Executive Summary

Whitehawk Therapeutics CEO David James and insider Bryan Ball collectively sold $228,000 worth of shares in open-market transactions over a seven-day period, with the largest single transaction exceeding $178,000. The sales represent a material portion of insider equity and occur amid recent negative market sentiment.

Key Financial Metrics

Direction

selling

Total Value

$417.5K

Insiders

2

Actionable Insight

Traders should monitor for potential downward pressure on WHWK shares, especially if additional selling follows. CEO participation in selling raises governance concerns and may signal lack of confidence in near-term prospects, particularly given the absence of offsetting buys.

Key Facts

CEO David James sold $266,423 worth of shares in two transactions on April 8 and April 9, 2026.
Bryan Ball sold $201,124 worth of shares on April 9 and April 10, 2026.
Total insider selling in the last 7 days: $417,547 across 4 transactions.
Total value of cluster analyzed in DOCUMENT 1: $228,000 (subset of full 7-day activity).
Combined sales represent approximately 0.26% of the company's $160M market cap.

Financial Impact

$417,547 in insider sales over 7 days, including CEO participation

insider sentimentownership concentrationmarket perception

Risk Factors

Perceived lack of confidence from top executive (CEO) could erode investor sentiment.
Concentrated selling may indicate anticipation of negative news or weak upcoming earnings.

Market Snapshot

Exchange

Nasdaq

Sector

Pharmaceutical Preparations

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

Document	Accession Number
CLUSTER Data (Synthetic)	cluster-WHWK-1776126893516

7 reports for WHWK

T+1T+5T+20T+60

100% Hit rate 4 of 4 directional calls best @ T+5▲ +17.44%May 13, 2026

Filters

Reports for WHWK — sortable, filterable
	Type				Now
May 29, 2026 11d ago	S-3 BEARISH ★ 6/10	$4.49 $4.15	▲ +7.57%	▲ +4.82%	$4.22 (+6.01%)
May 13, 2026 27d ago	8-K BEARISH ★ 8/10	$4.93 $4.07	▲ +17.44%	▲ +16.29%	$4.22 (+14.40%)
May 7, 2026 4w ago	8-K NEUTRAL ★ 3/10	$3.94 $4.93	▲ +25.13%	▲ +23.62%	$4.22 (+7.11%)
Apr 9, 2026 8w ago	Insider Cluster BEARISH ★ 7/10	$3.55 $4.23	▼ −19.15%	▼ −15.97%	$4.22 (−18.87%)
Apr 9, 2026 8w ago	Insider Cluster BEARISH ★ 6/10	$3.55 $4.23	▼ −19.15%	▼ −15.97%	$4.22 (−18.87%)
Apr 9, 2026 8w ago	Insider Cluster BEARISH ★ 7/10	$3.55 $4.23	▼ −19.15%	▼ −15.97%	$4.22 (−18.87%)
Mar 12, 2026 12w ago	8-K NEUTRAL ★ 4/10	$3.90 $3.59	▼ −7.95%	▼ −6.97%	$4.22 (+8.21%)

US Market Status

Market Closed — Opens Thu (9h 37m)

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access